426 related articles for article (PubMed ID: 7734296)
21. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts.
Noël A; Hajitou A; L'Hoir C; Maquoi E; Baramova E; Lewalle JM; Remacle A; Kebers F; Brown P; Calberg-Bacq CM; Foidart JM
Int J Cancer; 1998 Apr; 76(2):267-73. PubMed ID: 9537590
[TBL] [Abstract][Full Text] [Related]
22. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
[TBL] [Abstract][Full Text] [Related]
23. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium.
Tyagi SC; Kumar SG; Banks J; Fortson W
J Mol Cell Cardiol; 1995 Oct; 27(10):2177-89. PubMed ID: 8576934
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
25. Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells In vitro.
Song L; Porter DG; Coomber BL
Biol Reprod; 1999 Jan; 60(1):1-7. PubMed ID: 9858479
[TBL] [Abstract][Full Text] [Related]
26. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
[TBL] [Abstract][Full Text] [Related]
27. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).
Qin X; Chua PK; Ohira RH; Bryant-Greenwood GD
Biol Reprod; 1997 Apr; 56(4):812-20. PubMed ID: 9096860
[TBL] [Abstract][Full Text] [Related]
28. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts.
Svendsrud DH; Loennechen T; Winberg JO
Biochem Pharmacol; 1997 May; 53(10):1511-20. PubMed ID: 9260879
[TBL] [Abstract][Full Text] [Related]
29. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP.
Suzuki S; Sato M; Senoo H; Ishikawa K
Exp Cell Res; 2004 Feb; 293(2):259-66. PubMed ID: 14729463
[TBL] [Abstract][Full Text] [Related]
30. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.
Singer CF; Kronsteiner N; Marton E; Kubista M; Cullen KJ; Hirtenlehner K; Seifert M; Kubista E
Breast Cancer Res Treat; 2002 Mar; 72(1):69-77. PubMed ID: 12000221
[TBL] [Abstract][Full Text] [Related]
31. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
32. UVA irradiation stimulates the synthesis of various matrix-metalloproteinases (MMPs) in cultured human fibroblasts.
Herrmann G; Wlaschek M; Lange TS; Prenzel K; Goerz G; Scharffetter-Kochanek K
Exp Dermatol; 1993 Mar; 2(2):92-7. PubMed ID: 8156175
[TBL] [Abstract][Full Text] [Related]
33. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.
DiBattista JA; Pelletier JP; Zafarullah M; Fujimoto N; Obata K; Martel-Pelletier J
J Rheumatol Suppl; 1995 Feb; 43():123-8. PubMed ID: 7752115
[TBL] [Abstract][Full Text] [Related]
34. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
35. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
36. Ultraviolet B wavelength dependence for the regulation of two major matrix-metalloproteinases and their inhibitor TIMP-1 in human dermal fibroblasts.
Brenneisen P; Oh J; Wlaschek M; Wenk J; Briviba K; Hommel C; Herrmann G; Sies H; Scharffetter-Kochanek K
Photochem Photobiol; 1996 Nov; 64(5):877-85. PubMed ID: 8931389
[TBL] [Abstract][Full Text] [Related]
37. Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagenase) and 3 (stromelysin) and tissue inhibitor metalloproteinase 1 by human rheumatoid synovial fibroblasts.
Hiraoka K; Sasaguri Y; Komiya S; Zenmyo M; Inoue A; Morimatsu M
Exp Mol Pathol; 1993 Dec; 59(3):169-76. PubMed ID: 8137899
[TBL] [Abstract][Full Text] [Related]
38. Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells.
Bisson C; Blacher S; Polette M; Blanc JF; Kebers F; Desreux J; Tetu B; Rosenbaum J; Foidart JM; Birembaut P; Noel A
Int J Cancer; 2003 May; 105(1):7-13. PubMed ID: 12672023
[TBL] [Abstract][Full Text] [Related]
39. Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases.
Colige AC; Lambert CA; Nusgens BV; Lapière CM
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):215-21. PubMed ID: 1637302
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
